Mozeka · Pharmaceutical quality · UK and EU GMP

Your quality and microbiology team, without the headcount.

Quality consultancy and auditing for small pharmaceutical manufacturers, with contamination control at the core.

For start-ups and small pharmaceutical businesses with limited resources. We design contamination control into your quality system from day one, so it runs through the facility, the processes and the people rather than being bolted on after the first excursion.

Settle plate · Grade AFound · fixed · closed
Tamryn Hassel, founder of Mozeka

Tamryn Hassel

01Practising pharmaceutical microbiologist
02GMP Lead Auditor, MHRA-facing
03Responsible Person (GDP)
21 yrsin pharmaceutical quality, QC and microbiology
5quality systems designed, built and handed over. All still running.
GMP · GDPUK and EU. Sterile, non-sterile, ATMP and distribution
Lead AuditorAudits to one method, every report reviewed. Credentials →

How we help

Three ways we work with small manufacturers

Whether you are building your first quality system or keeping a licence, we bring the expertise a big company would have in-house, sized for your team.

Build

Build your quality system

We design and build your QMS and contamination control strategy with your team, from first licence onwards, and fix systems that have drifted.

Consultancy →

Check

Check where you stand

Fixed-price reviews before a licence or inspection, an annual review of your CCS, and supplier, contractor and self-inspection audits.

Readiness Review →CCS Effectiveness Review →Auditing →

Train

Train your team

Tailored GMP, microbiology and contamination control training, so your team can run the system themselves.

Training →

Client feedback

Specialist support that kept regulatory reports on time

Aseptic compounding manufacturer, UK

The client’s Quality Manager told us our microbiology, compounding and aseptic processing expertise brought significant value to the business. Our EM trending, report writing and regulatory documentation meant several reports reached the authorities within the required timelines that would otherwise have been late.

We managed the third-party laboratory engagement largely independently, and our face-to-face training was well received by the laboratory team. They described working with us as approachable, responsive and quick, with smooth onboarding, communication and invoicing.

Summary of client feedback, gathered independently after the engagement ended. References available on request.

Pricing

Two fixed-price reviews. Everything else, quoted for you.

Most of our work is consultancy, audits and training, sized to your site and stage, so we quote it after a short call. The two reviews are a fixed-price way to start, not a requirement.

Getting ready

Readiness Review

From £1,950

Remote. £4,500 with a site visit. Plus VAT.

  • ✓Your quality system against EU GMP
  • ✓Contamination control looked at specifically
  • ✓Prioritised gap report and debrief

What is included →

Already licensed

CCS Effectiveness Review

From £2,950

Remote. £4,950 with a site visit. Annual repeat £2,450. Plus VAT.

  • ✓Your CCS against PIC/S PI 058-1 and Annex 1
  • ✓12 months of data checked
  • ✓Prioritised action plan and debrief

What is included →

Everything else

Scoped to your site

On request

A written quote after a short call

  • ✓QMS and CCS builds
  • ✓Remediation after findings
  • ✓Supplier and self-inspection audits
  • ✓Training for your team
  • ✓Ongoing support retainers

Request a quote →

How we think about it

Contamination has eight ways in. One strategy closes them all.

Contamination does not come from one place, and it does not respect department boundaries. EU GMP Annex 1 expects sterile manufacturers to have a contamination control strategy that covers every route in, from suppliers to people to how you respond when something goes wrong. The same thinking protects any product. We build it as one connected system, not eight separate procedures.

01 / 08 · Route in

Premises and airflow

Where it gets inPressure cascades that drift, airflow that does not protect the critical zone, and surfaces that shed or cannot be cleaned.

What we build inGrades and zoning designed with the strategy from the start, airflow visualisation where it matters, and finishes chosen because they can be cleaned.

02 / 08 · Route in

Utilities

Where it gets inWater systems with dead legs and biofilm, compressed gases and steam that touch the product, and HVAC that slips out of maintenance.

What we build inEvery utility mapped into the risk assessment, sampling points and limits set by how each one is used, and maintenance tied to contamination risk.

03 / 08 · Route in

Equipment

Where it gets inEquipment that is hard to clean, sterilisation that has not been properly validated, and maintenance that breaks integrity.

What we build inDesign reviewed for cleanability before you buy, sterilisation validated, and maintenance planned around contamination risk.

04 / 08 · Route in

Suppliers and materials

Where it gets inRaw materials, components and container closures carrying bioburden, and outsourced sterilisation or testing nobody is overseeing.

What we build inRisk-based supplier qualification and audits, incoming material controls and bioburden limits, and quality agreements that say who controls what.

05 / 08 · Route in

The manufacturing process

Where it gets inOpen steps, transfers, hold times and interventions nobody planned for.

What we build inA process risk assessment, defined interventions tested in your process simulation, validated hold times and in-process bioburden controls.

06 / 08 · Route in

People

Where it gets inGowning, behaviour, movement, and the shortcut taken on a busy shift.

What we build inGowning qualification, aseptic behaviour training and flows designed so the right thing is the easy thing.

07 / 08 · Route in

Cleaning and disinfection

Where it gets inThe wrong agent, the wrong contact time, residues left behind, and no sporicide in the rotation.

What we build inAgents and contact times that are validated, sporicides used where they are needed, and a programme adjusted to what your EM data shows.

08 / 08 · Route in

Monitoring and response

Where it gets inMonitoring in the wrong places, data nobody trends, and excursions closed without a root cause.

What we build inAn EM programme located by risk, trending that is actually read, and investigations that find the root cause and CAPA that holds.

Tap a route, or watch them in turn.

YOUR PRODUCTand the patientONE STRATEGYPremises & airflowUtilitiesEquipmentSuppliers & materialsManufacturing processPeopleCleaning & disinfectionMonitoring & response

Free checklist

Is your contamination control strategy still fit for purpose?

PIC/S PI 058-1 now expects your CCS to be reviewed on an ongoing basis, and at least once a year. Our 7-page checklist shows where yours stands in about an hour.

Coming in 2027

The Subculture by Mozeka

A reference of pharma-relevant microorganisms that tells you what a recovery means for your facility.

The Mozekan →

A free club for start-ups building their first quality system, and for people building their careers in quality: the QMS Tracker, monthly build cohorts, training and a community of peers, with paid modules and Mozeka’s consultants when you need them. Apply for a founding place →

Built so small quality teams can spend their time on what’s unique to them, not on what the industry already knows.

Not sure where you stand?

Tell us where you are, and we will tell you what to do first.